BIOSEARCH overview

SEOUL, Republic of Korea and LONDON, June 09, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, and LGC, a global leader in the life science tools sector headquartered in London, announced that the companies signed an exclusive contract to scale production of OliX’s OLX104C, an investigational RNAi therapeutic in development for the treatment of androgenic alopecia, also known as hair loss. Under the terms of the agreement, LGC will...

SUWON, Republic of Korea and LONDON, June 16, 2020 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc . (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company signed an exclusive contract with LGC Biosearch Technologies Inc. (LGC), a contract development and manufacturing organization (CDMO) and part of the global life sciences tools company headquartered in London, to scale production of OliX’s OLX301D therapeutic candidate. Under the terms of the agreement,...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......